IFRX
InflaRx N.V.
NASDAQ: IFRX · HEALTHCARE · BIOTECHNOLOGY
$1.98
+18.56% today
Updated 2026-04-29
Market cap
$116.39M
P/E ratio
—
P/S ratio
3,968.21x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
InflaRx N.V. (IFRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.31M | $-4.99M | $-12.15M | $-23.71M | $-43.20M | $-36.53M | $-39.94M | $-33.74M | $-37.81M | $-48.56M | $-33.92M |
| Capital expenditures | $13000.00 | $53000.00 | $149000.00 | $806000.00 | $594889.00 | $94189.00 | $37778.00 | $162391.00 | $81100.00 | $46871.00 | $111127.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $243000.00 | $868000.00 | $4.55M | $12.09M | $6.83M | $1.12M | $4.33M | $6.04M | $3.41M | $4.07M | $4.44M |
| Free cash flow | $-3.32M | $-5.05M | $-12.30M | $-24.52M | $-43.80M | $-36.62M | $-39.97M | $-33.91M | $-37.89M | $-48.60M | $-34.03M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |